Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma.
Nat Commun. 2022 Jun 29;13(1):3750. doi: 10.1038/s41467-022-31430-0.
Nat Commun. 2022.
PMID: 35768438
Free PMC article.
Preferences and Priorities for Relapsed Multiple Myeloma Treatments Among Patients and Caregivers in the United States.
Auclair D, Mansfield C, Fiala MA, Chari A, Cole CE, Kaufman JL, Orloff GJ, Siegel DS, Zonder JA, Mange B, Yesil J, Dalal M, Mikhael JR.
Auclair D, et al. Among authors: yesil j.
Patient Prefer Adherence. 2022 Mar 1;16:573-585. doi: 10.2147/PPA.S345906. eCollection 2022.
Patient Prefer Adherence. 2022.
PMID: 35256844
Free PMC article.
Item in Clipboard
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing.
D'Agostino M, Zaccaria GM, Ziccheddu B, Rustad EH, Genuardi E, Capra A, Oliva S, Auclair D, Yesil J, Colucci P, Keats JJ, Gambella M, Bringhen S, Larocca A, Boccadoro M, Bolli N, Maura F, Gay F.
D'Agostino M, et al. Among authors: yesil j.
Clin Cancer Res. 2020 Sep 15;26(18):4832-4841. doi: 10.1158/1078-0432.CCR-20-0951. Epub 2020 Jul 2.
Clin Cancer Res. 2020.
PMID: 32616499
Free article.
Item in Clipboard
High Dimensional Immune Profiling of Smoldering Multiple Myeloma Distinguishes Distinct Tumor Microenvironments.
Fernandez N, Perumal D, Rahman A, Kim-Schulze S, Yesil J, Auclair D, Adams H 3rd, Parekh S, Gnjatic S, Cho HJ.
Fernandez N, et al. Among authors: yesil j.
Clin Lymphoma Myeloma Leuk. 2022 Nov;22(11):853-862. doi: 10.1016/j.clml.2022.07.001. Epub 2022 Jul 16.
Clin Lymphoma Myeloma Leuk. 2022.
PMID: 35945129
Item in Clipboard
Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma.
Laganà A, Perumal D, Melnekoff D, Readhead B, Kidd BA, Leshchenko V, Kuo PY, Keats J, DeRome M, Yesil J, Auclair D, Lonial S, Chari A, Cho HJ, Barlogie B, Jagannath S, Dudley JT, Parekh S.
Laganà A, et al. Among authors: yesil j.
Leukemia. 2018 Jan;32(1):120-130. doi: 10.1038/leu.2017.197. Epub 2017 Jun 23.
Leukemia. 2018.
PMID: 28642592
Item in Clipboard
Cite
Cite